Literature DB >> 17567982

Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma.

Hai-Jun Zhou1, Lan V Pham, Archito T Tamayo, Yen-Chiu Lin-Lee, Lingchen Fu, Linda C Yoshimura, Richard J Ford.   

Abstract

CD40 is an integral plasma membrane-associated member of the TNF receptor family that has recently been shown to also reside in the nucleus of both normal B cells and large B-cell lymphoma (LBCL) cells. However, the physiological function of CD40 in the B-cell nucleus has not been examined. In this study, we demonstrate that nuclear CD40 interacts with the NF-kappaB protein c-Rel, but not p65, in LBCL cells. Nuclear CD40 forms complexes with c-Rel on the promoters of NF-kappaB target genes, CD154, BLyS/BAFF, and Bfl-1/A1, in various LBCL cell lines. Wild-type CD40, but not NLS-mutated CD40, further enhances c-Rel-mediated Blys promoter activation as well as proliferation in LBCL cells. Studies in normal B cells and LBCL patient cells further support a nuclear transcriptional function for CD40 and c-Rel. Cooperation between nuclear CD40 and c-Rel appears to be important in regulating cell growth and survival genes involved in lymphoma cell proliferation and survival mechanisms. Modulating the nuclear function of CD40 and c-Rel could reveal new mechanisms in LBCL pathophysiology and provide potential new targets for lymphoma therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17567982      PMCID: PMC1976364          DOI: 10.1182/blood-2007-02-073080

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  53 in total

Review 1.  The CD40-CD154 interaction in B cell-T cell liaisons.

Authors:  Gail A Bishop; Bruce S Hostager
Journal:  Cytokine Growth Factor Rev       Date:  2003 Jun-Aug       Impact factor: 7.638

2.  CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells.

Authors:  Pau Serra; Abdelaziz Amrani; Jun Yamanouchi; Bingye Han; Shari Thiessen; Toshihiro Utsugi; Joan Verdaguer; Pere Santamaria
Journal:  Immunity       Date:  2003-12       Impact factor: 31.745

3.  Homeostatic cell-cycle control by BLyS: Induction of cell-cycle entry but not G1/S transition in opposition to p18INK4c and p27Kip1.

Authors:  Xiangao Huang; Maurizio Di Liberto; Adam F Cunningham; Lin Kang; Shuhua Cheng; Scott Ely; Hsiou-chi Liou; Ian C M Maclennan; Selina Chen-Kiang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-10       Impact factor: 11.205

4.  NF-kappaB is involved in the regulation of CD154 (CD40 ligand) expression in primary human T cells.

Authors:  M Srahna; J E Remacle; K Annamalai; S Pype; D Huylebroeck; M A Boogaerts; P Vandenberghe
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

5.  NF-kappa B-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bfl-1/A1.

Authors:  Leonard C Edelstein; Lynn Lagos; Matthew Simmons; Hemamalini Tirumalai; Céline Gélinas
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

6.  Nuclear localization of EGF receptor and its potential new role as a transcription factor.

Authors:  S Y Lin; K Makino; W Xia; A Matin; Y Wen; K Y Kwong; L Bourguignon; M C Hung
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

7.  The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

Authors:  Kerry J Savage; Stefano Monti; Jeffery L Kutok; Giorgio Cattoretti; Donna Neuberg; Laurence De Leval; Paul Kurtin; Paola Dal Cin; Christine Ladd; Friedrich Feuerhake; Ricardo C T Aguiar; Sigui Li; Gilles Salles; Francoise Berger; Wen Jing; Geraldine S Pinkus; Thomas Habermann; Riccardo Dalla-Favera; Nancy Lee Harris; Jon C Aster; Todd R Golub; Margaret A Shipp
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

8.  BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.

Authors:  Estefania Claudio; Keith Brown; Sun Park; Hongshan Wang; Ulrich Siebenlist
Journal:  Nat Immunol       Date:  2002-09-23       Impact factor: 25.606

9.  Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.

Authors:  Brendan N D'Souza; Leonard C Edelstein; Pamela M Pegman; Sinéad M Smith; Sinéad T Loughran; Ann Clarke; Anja Mehl; Martin Rowe; Céline Gélinas; Dermot Walls
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B.

Authors:  I Berberich; G L Shu; E A Clark
Journal:  J Immunol       Date:  1994-11-15       Impact factor: 5.422

View more
  14 in total

1.  BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells.

Authors:  Lingchen Fu; Yen-Chiu Lin-Lee; Lan V Pham; Archito T Tamayo; Linda C Yoshimura; Richard J Ford
Journal:  Blood       Date:  2009-03-03       Impact factor: 22.113

2.  13q14 deletions in CLL involve cooperating tumor suppressors.

Authors:  Alexey Palamarchuk; Alexey Efanov; Natalya Nazaryan; Urmila Santanam; Hansjuerg Alder; Laura Rassenti; Thomas Kipps; Carlo M Croce; Yuri Pekarsky
Journal:  Blood       Date:  2010-01-13       Impact factor: 22.113

3.  Release the ink4a/arf growth suppression by "u" and "me"?

Authors:  Shuo Qie; Nianli Sang
Journal:  Cell Cycle       Date:  2011-01-15       Impact factor: 4.534

4.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

Review 5.  The nuclear signaling of NF-kappaB: current knowledge, new insights, and future perspectives.

Authors:  Fengyi Wan; Michael J Lenardo
Journal:  Cell Res       Date:  2009-12-08       Impact factor: 25.617

6.  p52 Activation in monomorphic B-cell posttransplant lymphoproliferative disorder/diffuse large B-cell lymphoma without BAFF-R expression.

Authors:  Alexis Proust; Patricia Rincé; Rita Creidy; Thierry Lazure; Irène Joab; Loïc Garçon; Monique Fabre; Catherine Guettier; Martine Raphael
Journal:  Am J Pathol       Date:  2011-08-24       Impact factor: 4.307

Review 7.  Recent advances in the genetics of autoimmune disease.

Authors:  Peter K Gregersen; Lina M Olsson
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

8.  Induction of the alternative NF-κB pathway by lymphotoxin αβ (LTαβ) relies on internalization of LTβ receptor.

Authors:  Corinne Ganeff; Caroline Remouchamps; Layla Boutaffala; Cécile Benezech; Géraldine Galopin; Sarah Vandepaer; Fabrice Bouillenne; Sandra Ormenese; Alain Chariot; Pascal Schneider; Jorge Caamaño; Jacques Piette; Emmanuel Dejardin
Journal:  Mol Cell Biol       Date:  2011-09-06       Impact factor: 4.272

9.  Inhibitor of kappa B epsilon (IκBε) is a non-redundant regulator of c-Rel-dependent gene expression in murine T and B cells.

Authors:  Joanna M Clark; Karolina Aleksiyadis; Alex Martin; Kay McNamee; Tharsana Tharmalingam; Richard O Williams; Sylvie Mémet; Andrew P Cope
Journal:  PLoS One       Date:  2011-09-06       Impact factor: 3.240

10.  REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis.

Authors:  Peter K Gregersen; Chistopher I Amos; Annette T Lee; Yue Lu; Elaine F Remmers; Daniel L Kastner; Michael F Seldin; Lindsey A Criswell; Robert M Plenge; V Michael Holers; Ted R Mikuls; Tuulikki Sokka; Larry W Moreland; S Louis Bridges; Gang Xie; Ann B Begovich; Katherine A Siminovitch
Journal:  Nat Genet       Date:  2009-06-07       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.